Drug intelligence / Profile preview

DW2012

Development stage
Preclinical
Lead developer
Dongwha Pharmaceutical
Modality
Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral
01

Overview

DW2012 is a probiotic functional material candidate, specifically a strain of *Lactobacillus fermentum*, developed by Dongwha Pharmaceutical to improve sleep quality. Categorized within the company's 'Functional Materials' pipeline, it is intended for use as a health functional food (HFF) rather than a prescription pharmaceutical. DW2012 is designed to enhance sleep health, potentially through the modulation of the gut-brain axis and the regulation of neurotransmitters associated with the sleep-wake cycle. As of recent reports, the strain is undergoing human application trials in South Korea to evaluate its efficacy in improving sleep duration and efficiency, targeting the growing consumer demand for natural, non-pharmacological sleep aids.

Beyond the preview

Go deeper on DW2012.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DW2012.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call